Covalon Technologies Ltd. (COV)

2.270
-0.030(-1.30%)
  • Volume:
    3,775
  • Bid/Ask:
    2.230/2.280
  • Day's Range:
    2.190 - 2.270
  • Type:Equity
  • Market:Canada
  • ISIN:CA22282D3022
  • CUSIP:22282D302

COV Overview

Prev. Close
2.3
Day's Range
2.19-2.27
Revenue
27.47M
Open
2.19
52 wk Range
1.09-3.15
EPS
-0.04
Volume
3,775
Market Cap
58.72M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
15,074
P/E Ratio
-
Beta
1.96
1-Year Change
84%
Shares Outstanding
25,868,677
Next Earnings Date
Jan. 27, 2022
What is your sentiment on Covalon Technologies Ltd.?
or
Vote to see community's results!

Covalon Technologies Ltd. Company Profile

Employees
37
Market
Canada

Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, the United Kingdom, Europe, the Middle East, Asia, Latin America, and internationally. The company has five proprietary platform technologies, including collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; antimicrobial silicone adhesive platform that is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity; medical coating platform, a proprietary process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device; aquaguard moisture barrier technology, an impermeable moisture barrier that allows the clinician or patient to cover wounds, dressings, and intravenous sites to keep them dry; and covaguard antimicrobial sanitizing technology that incorporates Benzalkonium Chloride into a lipid delivery system to surfaces and skin to kill viruses and bacteria. Its products include wound care dressings; surgical and peri-operative products; infection management products; moisture barriers; and antimicrobial sanitizers under the Covalon brand name. The company sells its products through third-party distribution networks and company’s direct sales force. It serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians’ offices. The company is headquartered in Mississauga, Canada.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellSellSell
Technical IndicatorsSellSellStrong SellStrong SellStrong Buy
SummarySellSellStrong SellStrong SellNeutral
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.